ResMed Inc. (RMD)
$234.60+1.98%Close
BUYRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $34.0B
- Beta
- 0.77
- Div yield
- 1.11%
- P/E (TTM)
- 21.14
- Short % float
- 8.87%
- Days to cover
- 9.9
- SI change
- -10.0%
- 1W
- +5.27%
- 1M
- +7.48%
- vs SPY 1W
- +4.85%
- vs SPY 1M
- +5.42%
Industry peers
FMP comparable companies · ranked by market cap
- ISRGBUYIntuitive Surgical, Inc.$149.8BRECOVERYQ 29$423.96+0.87%
- MDTSELLMedtronic Plc$113.3BRECOVERYQ 14$88.48+3.90%
- BSXSELLBoston Scientific Corporation$63.5BRECOVERYQ 6$42.73+2.60%
- GEHCBUYGE HealthCare Technologies Inc.$29.7BRECOVERYQ 6$65.74+3.04%
- PHGSELLKoninklijke Philips N.V.$23.7BRECOVERYQ 10$24.24+2.06%
- FSPKFFisher & Paykel Healthcare Corporation Limited$15.2B$25.81
- GNGBYGetinge AB (publ)$6.9B$25.32
- TFXSELLTeleflex Incorporated$5.5BBEARQ 11$125.12+0.46%
- INSPSELLInspire Medical Systems, Inc.$2.0BRECOVERYQ 14$68.89+3.77%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RMD?
- LOPJLB’s latest quantitative signal on ResMed Inc. (RMD) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is RMD in?
- ResMed Inc. (RMD) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does ResMed Inc. (RMD) do?
- ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and c…